Banham John Michael Middlecott 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed May 23, 2013
Insider Transaction Report
Form 4
Banham John Michael Middlecott
Director
Transactions
- Award
Option
2013-05-22+5,000→ 5,000 totalExercise: $2.99Exp: 2023-05-22→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]These options are exercisable over a four-year period with 1/48 of the options granted vesting on a monthly basis.
- [F2]These options were granted to Sir Banham for his services as chairman of the Audit Committee of the board of directors of Cyclacel Pharmaceuticals, Inc.